AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2025
Apr 2, 2025
29755_dirs_2025-04-02_7cbe1e25-3063-4d15-874e-62ff5d85eef0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-03-31
Reporting Person: GONZALEZ RICHARD A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | Common Stock, $0.01 par value | G | 2450 | — | Disposed | 386479 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4